8tmr
Crystal structure of KPC-44 carbapenemase complexed with avibactamCrystal structure of KPC-44 carbapenemase complexed with avibactam
Structural highlights
FunctionPublication Abstract from PubMedKlebsiella pneumoniae carbapenemase 2 (KPC-2) is an important source of drug resistance as it can hydrolyze and inactivate virtually all beta-lactam antibiotics. KPC-2 is potently inhibited by avibactam via formation of a reversible carbamyl linkage of the inhibitor with the catalytic serine of the enzyme. However, the use of avibactam in combination with ceftazidime (CAZ-AVI) has led to the emergence of CAZ-AVI resistant variants of KPC-2 in clinical settings. One such variant, KPC-44, bears a 15 amino-acid duplication in one of the active site loops (270-loop). Here, we show that the KPC-44 variant exhibits higher catalytic efficiency in hydrolyzing ceftazidime, lower efficiency towards imipenem and meropenem, and a similar efficiency in hydrolyzing ampicillin, when compared to the wild-type KPC-2 enzyme. In addition, the KPC-44 variant enzyme exhibits 12-fold lower avibactam carbamylation efficiency than the KPC-2 enzyme. An X-ray crystal structure of KPC-44 showed that the 15 amino acid duplication results in an extended and partially disordered 270-loop and also changes the conformation of the adjacent 240-loop, which in turn has altered interactions with the active-site omega loop. Furthermore, a structure of KPC-44 with avibactam revealed that formation of the covalent complex results in further disorder in the 270-loop, suggesting that rearrangement of the 270-loop of KPC-44 facilitates avibactam carbamylation. These results suggest that the duplication of 15 amino acids in the KPC-44 enzyme leads to resistance to CAZ-AVI by modulating the stability and conformation of the 270-, 240-, and omega-loops. Klebsiella pneumoniae carbapenemase variant 44 (KPC-44) acquires ceftazidime-avibactam resistance by altering the conformation of active site loops.,Sun Z, Lin H, Hu L, Neetu N, Sankaran B, Wang J, Prasad BVV, Palzkill T J Biol Chem. 2023 Nov 22:105493. doi: 10.1016/j.jbc.2023.105493. PMID:38000656[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. References
|
|